GRCE   $4.38  -1.35% Market Closed After Close 4.5 2.74%

Grace Therapeutics, Inc.

EMA (20): 2026-02-17 the price crossed up the moving average line and getting closer to the MA, which means that the upside trend weakens.

EMA (50): 2026-02-06 the price crossed up the moving average line and getting closer to the MA, which means that the upside trend weakens.

EMA (100): 2025-11-18 the price crossed up the moving average line and demonstrates an upside trend.

MACD: Oscillator MACD is in the positive territory it's higher than the signal line and falls. These factors mean that the growing trend persists, but the growth rate is declining. Last signal: entrance to the overbought zone.

Stochastic: The stochastic indicator is in the upper part of the neutral territory and it falls. These factors indicate that the downside trend is confirmed. Last signal: main and signal line crossing.

Trend Type linear up
Power strong
Trend Pattern
EMA (20) Signals bullish reversal
EMA (20) Yield -0.25%
EMA (20) date of signal Feb. 17, 2026, 3 a.m.
EMA (50) Signals bullish reversal
EMA (50) Yield 9.17%
EMA (50) date of signal Feb. 6, 2026, 3 a.m.
EMA (100) Signals bullish reversal
EMA (100) Yield 24.37%
EMA (100) date of signal Nov. 18, 2025, 3 a.m.
RSI Signals bullish weakening
RSI (14) Yield -3.44%
RSI (14) date of signal March 2, 2026, 3 a.m.
MACD Signals bullish weakening
MACD Yield -3.44%
MACD date of signal March 2, 2026, 3 a.m.
Stochastic Signals bullish weakening
Stochastic Yield -3.44%
Stochastic date of signal March 2, 2026, 3 a.m.
Updated March 4, 2026, 8:30 p.m.